To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women
NCT02862171
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
941
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Prevention
Interventions
DRUG:
Dapivirine Vaginal Ring-004
Sponsor
International Partnership for Microbicides, Inc.